Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041762 | SCV000065458 | benign | not specified | 2010-07-26 | criteria provided, single submitter | clinical testing | Gly4838Glu in exon 66 of USH2A: This variant is not expected to have clinical si gnificance because this amino acid position in not conserved (chimp has a Glu at this amino acid position) and is listed in dbSNP (rs41315587 - no frequency dat a). In addition, this variant has been identified in 4/191 (2.1%) of individuals tested by our laboratory with at least 3/4 of Black or Hispanic background sugg esting this variant is a common benign variant in these populations. |
Gene |
RCV000041762 | SCV000169771 | benign | not specified | 2011-07-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000041762 | SCV000231956 | benign | not specified | 2014-05-21 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000714161 | SCV000844844 | benign | not provided | 2018-05-24 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000714161 | SCV000884847 | benign | not provided | 2023-09-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000714161 | SCV001716454 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450794 | SCV004183051 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001276148 | SCV004183052 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003887898 | SCV004707212 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Breakthrough Genomics, |
RCV000714161 | SCV005287595 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001276148 | SCV001462002 | benign | Usher syndrome type 2A | 2020-09-16 | no assertion criteria provided | clinical testing |